Search Results

DAPAVIB 10

DAPAGLIFLOZIN 10mg. IP

Send Enquiry

CURE

Tablets

Packaging and packing Type

Alu Alu | 2x14

MRP :

₹203

PTR :

₹145

PTS :

₹130.5

The newest class of antihyperglycemic medications. (Plosker, 2012) A highly potent drug that reduces hyperglycemia by increasing urinary glucose excr... Read More

Composition

DAPAGLIFLOZIN 10mg. IP

Send Enquiry

India’s Largest Pharma Franchise

100%

Genuine Products

Secure

Payments

24 x 7

Customer Support

About the product

Description

The newest class of antihyperglycemic medications. (Plosker, 2012) A highly potent drug that reduces hyperglycemia by increasing urinary glucose excretion. (M Nauck, 2013) A beneficial therapeutic therapy for patients with type 2 diabetes and improves postprandial blood glucose. (Plosker, 2012) An effective drug in individuals both early and late in the course of diabetes. (Anders, 2014) Ameliorates glycemic control, reduces weight and fat mass, without affecting bone mineral density in type 2 diabetes subjects inadequately controlled on metformin. (J Bolinder, 2014) Improves glycemic parameters in patients with type 2 diabetes when used as monotherapy or in combination with metformin, glimepiride, pioglitazone, sitagliptin, or insulin. (Vivian, 2015) Represents a novel approach to the management of type 2 diabetes mellitus. (Niren K Shah, 2012) Significantly increases urinary glucose excretion and decreases glucose concentration in the bloodstream. (Theodosios D. Filippatos, 2015) Possesses blood pressure-lowering properties and leads to improvement in HbA1C measurements.(Michael A Weber, 2016) Reduces weight and produces less hypoglycemia than glipizide in type 2 diabetes patients who are inadequately controlled with metformin. (M Nauck, 2013) A well-tolerated medicine associated with sustained glycemic efficacy and greater reductions in body weight and systolic blood pressure than glipizide. (S Del Prato, 2015) A safe and effective drug as monotherapy or as an add-on to insulin or oral antidiabetic agents in type 2 diabetes patients. (Paola Fioretto, 2015)

Side Effects

Hives, Difficult breathing, Nausea, Vomiting, Stomachache

Indication

Type 2 Diabetes

Important Notice

Temp data

Storage Condition

Product details for storage condition Product details for storage condition Product details for storage condition Product details for storage condition

Looking into the future of healthcare

Contact

Plot No 4, HSIIDC IT PARK, Sector 22,Panchkula, Haryana, India 134109

Phone: 9888988858

Business Hours

Mon-Sat: 9AM to 6PM

Franchise Enquiry

Request a callback to get more information about becoming a PCD Franchise Owner***

    Send Enquiry

    Request a callback to get more information about becoming a PCD Franchise Owner